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Abstract: A high retention enzymatic bioreactor was developed by coupling membrane distillation
with an enzymatic bioreactor (MD-EMBR) to investigate the degradation of 13 phenolic and
17 non-phenolic trace organic contaminants (TrOCs). TrOCs were effectively retained (90–99%) by
the MD membrane. Furthermore, significant laccase-catalyzed degradation (80–99%) was achieved
for 10 phenolic and 3 non-phenolic TrOCs that contain strong electron donating functional groups.
For the remaining TrOCs, enzymatic degradation ranged from 40 to 65%. This is still higher than those
reported for enzymatic bioreactors equipped with ultrafiltration membranes, which retained laccase
but not the TrOCs. Addition of three redox-mediators, namely syringaldehyde (SA), violuric acid
(VA) and 1-hydroxybenzotriazole (HBT), in the MD-EMBR significantly broadened the spectrum of
efficiently degraded TrOCs. Among the tested redox-mediators, VA (0.5 mM) was the most efficient
and versatile mediator for enhanced TrOC degradation. The final effluent (i.e., membrane permeate)
toxicity was below the detection limit, although there was a mediator-specific increase in toxicity of
the bioreactor media.
Keywords: enzymatic membrane bioreactor (EMBR); laccase; membrane distillation; redox-mediators;
trace organic contaminants (TrOCs)
1. Introduction
Laccase (EC 1.10.3.2), a copper-containing oxidoreductase enzyme, has been studied extensively
for the degradation of recalcitrant compounds such as phenols and aromatic hydrocarbons [1–5].
In recent years, laccase-catalyzed degradation of trace organic contaminants (TrOCs) such as
pharmaceuticals, pesticides, personal care products, industrial chemicals and steroid hormones has
gained significant attention [6,7]. These TrOCs occur ubiquitously in municipal wastewater and have
the potential to adversely affect aquatic ecosystems and human health [8–10].
TrOC degradation by laccase depends on a number of factors including pH, temperature,
chemical structure of TrOCs and laccase properties [11–13]. In general, effective laccase-catalyzed
degradation of TrOCs containing electron donating functional groups (EDGs) such as amine (–NH2),
alkoxy (–OR) or hydroxyl (–OH) was observed. On the other hand, degradation of TrOCs containing
electron withdrawing functional groups (EWGs) such as halogen (–X), amide (–CONR2) or nitro
Appl. Sci. 2017, 7, 879; doi:10.3390/app7090879 www.mdpi.com/journal/applsci
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(–NO2) has been reported to be poor or unstable [11,14]. Degradation of TrOCs can be improved by
adding different natural and synthetic redox-mediators that are low molecular weight compounds
capable of exchanging electrons between laccase and TrOCs [15–17].
Initial studies have assessed the performance of laccase-catalyzed TrOC degradation in batch
enzymatic bioreactors due to the concern of enzyme washout in a continuous flow system. In an attempt
to prevent enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed by coupling
an ultrafiltration (UF) membrane to an enzymatic bioreactor [18,19]. Interestingly, during the operation
of the EMBR, adsorption of some hydrophobic TrOCs (e.g., amitriptyline, oxybenzone and octocrylene)
onto the enzyme gel layer over the membrane surface resulted in enhanced degradation of the adsorbed
compounds [18]. In another study, removal of four non-phenolic TrOCs, namely atrazine, sulfamethoxazole,
diclofenac and carbamazepine was improved by 15–25% following the addition of granular activated
carbon (GAC) in EMBR. This was probably because simultaneous adsorption of laccase and TrOCs on
GAC promoted the interaction of TrOCs with the active sites of laccase [20]. Results from previous studies
indicate the complementarity of simultaneous laccase and TrOC retention within EMBR in contrast to only
laccase retention by UF membranes utilized in the previously developed EMBRs. Hence, in this study,
it is postulated that the integration of an enzymatic bioreactor with a high retention membrane could
facilitate the degradation of resistant TrOCs by retaining both laccase and TrOCs.
Different configurations of conventional activated sludge-based high retention membrane
bioreactors (HR-MBR), employing membrane distillation (MD), forward osmosis (FO) or nanofiltration
(NF) membranes, have been investigated for advanced wastewater treatment [21–24]. Complete TrOC
retention in HR-MBR improved the membrane permeate quality, but the poor removal of certain groups
of TrOCs such as those containing EWGs led to their accumulation in the bioreactor. This indicates the
necessity of formulating means to enhance biodegradation of TrOCs. In this context, it is noteworthy
that recent reports confirm enhanced laccase-catalyzed degradation of selected TrOCs that are not
amenable to degradation by conventional activated sludge [25,26]. However, the performance of
a high retention—enzymatic membrane bioreactor for the removal of a wide range of TrOCs remains
to be elucidated.
Among the high retention membrane systems, in MD, a vapor-liquid interface is developed
around a hydrophobic micro-porous membrane that allows the water to pass through the membrane
via diffusion due to vapor pressure gradient. Compared to conventional distillation processes such
as fractional distillation, the MD process requires low temperature and could be operated by using
low grade heat or solar energy [27,28]. Since the mass transfer in the MD process occurs in gaseous
phase, it can theoretically achieve 100% retention of all non-volatile compounds [29]. The standalone
MD process has been investigated for seawater desalination [30], industrial wastewater treatment [31],
municipal wastewater treatment [32] and TrOC removal [29,33]. Thus, the MD process was selected
for coupling to an enzymatic bioreactor in this study.
The aim of this study was to assess the performance of a laccase based membrane distillation—
enzymatic membrane bioreactor (MD-EMBR) for the removal of TrOCs having diverse physicochemical
properties (e.g., EDGs/EWGs, hydrophobicity and phenolic/non-phenolic moieties). A special focus
was given to the improvement in TrOC degradation due to the addition of three redox-mediators,
namely syringaldehyde (SA), violuric acid (VA) and 1-hydroxybenzotriazole (HBT) at different
concentrations. In addition, performance of laccase-mediator systems was systematically compared
based on TrOC degradation, enzyme stability and effluent toxicity.
2. Materials and Methods
2.1. Trace Organic Contaminants (TrOCs), Laccase and Mediators
A set of 30 TrOCs comprising 10 pharmaceuticals, four personal care products, six pesticides,
four industrial chemicals, five steroid hormones and one phytoestrogen was selected based on their
widespread occurrence in surface water bodies (see Supplementary Data Table S1). Key physicochemical
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properties of the TrOCs including molecular weight, water solubility, hydrophobicity (log D) and volatility
(pKH) are presented in Table 1. All TrOCs were purchased from Sigma Aldrich (Sydney, NSW, Australia),
and were of analytical grade. A stock solution (25 mg/L) containing the mixture of 30 TrOCs was prepared
in pure methanol, and kept in dark at −18 ◦C.
Laccase from genetically modified Aspergillus oryzae was supplied by Novozymes Australia Pty
Ltd (Sydney, NSW, Australia). According to the supplier, the enzyme has a molecular weight, purity,
activity and density of 56 KDa, 10% (w/w), 150,000 µM(DMP)/min (measured using 2,6-dimethoxy
phenol, DMP, as substrate) and 1.12 g/mL, respectively.
Two N–OH type redox-mediators, namely 1-hydroxybenzotriazole (HBT) and violuric acid
(VA), and one phenolic redox-mediator, namely syringaldehyde (SA), were used in this study (see
Supplementary Data Table S2). The selected mediators all follow hydrogen atom transfer (HAT)
pathway for TrOC degradation [34], but the oxidation of phenolic and N–OH type redox-mediators by
laccase produces highly reactive phenoxyl and aminoxyl radicals, respectively. The mediators were
also purchased from Sigma Aldrich (Sydney, NSW, Australia). A separate stock solution (50 mM) of
each redox-mediator was prepared, and stored at 4 ◦C in dark.














Primidone C12H14N2O 218.25 0.83 1500 6.08 × 10−11 13.93
Ketoprofen C16H14O3 254.28 0.19 554,000 3.32 × 10−8 13.70
Naproxen C14H14O3 230.26 0.73 435,000 3.01 × 10−7 12.68
Gemfibrozil C15H22O3 250.33 2.07 263,000 6.13 × 10 −7 12.11
Metronidazole C6H9N3O3 171.15 −0.14 29,000 2.67 × 10−7 11.68
Diclofenac C14H11Cl2NO2 296.15 1.77 20,000 1.59 × 10−7 11.51
Fenoprop C9H7Cl3O3 269.51 −0.13 230,000 2.13 × 10−6 11.48
Ibuprofen C13H18O2 206.28 0.94 928,000 1.39 × 10−4 10.39
Ametryn C9H17N5S 27.33 2.97 140 1.72 × 10−6 9.35
Clofibric acid C10H11ClO3 214.65 −1.06 100,000 1.03 × 10−4 9.54
Carbamazepine C15H12N2O 236.27 1.89 220 5.78 × 10−7 9.09
Octocrylene C24H27N 361.48 6.89 0.36 2.56 × 10−9 8.47
Amitriptyline C20H23N 277.40 2.28 83 1.50 × 10−6 8.18
Atrazine C8H14ClN5 215.68 2.64 69 1.27 × 10−5 7.28
Propoxur C11H15NO3 209.24 1.54 800 1.53 × 10−3 6.28
Benzophenone C13H10O 182.22 3.21 150 8.23 × 10−4 5.88
DEET C12H17NO 191.3 2.42 1000 5.6 × 10−3 5.85
Phenolic Compounds
Enterolactone C18H18O4 288.38 2.53 200 3.29 × 10−13 15.20
Estriol C18H24O3 298.33 1.89 32 1.34 × 10−9 10.78
17α-Ethinylestradiol C20H24O2 269.40 4.11 3.9 3.74 × 10−9 9.47
Oxybenzone C14H12O3 228.24 3.89 2700 5.26 × 10−6 9.23
Estrone C18H22O2 270.37 3.62 5.9 1.54 × 10−8 9.03
17β-Estradiol C18H24O2 272.38 4.15 3 9.82 × 10−9 8.93
17β-Estradiol-17-acetate C20H26O3 314.42 5.11 1.9 9.88 × 10−9 8.67
Bisphenol A C15H16O2 228.29 3.64 73 5.34 × 10−7 8.66
Salicylic acid C7H6O3 138.12 −1.13 2240 8.2 × 10−5 8.18
Pentachlorophenol C6HCl5O 266.34 2.85 4800 3.49 × 10−4 7.59
Triclosan C12H7Cl3O2 289.54 5.28 19 3.26 × 10−5 6.18
4-tert-Butylphenol C10H14O 150.22 3.40 1000 0.0361 5.15
4-tert-Octylphenol C14H22O 206.32 5.18 62 1.98 × 10−3 5.06
2.2. Experimental Setup
The laboratory scale MD-EMBR setup comprised a glass enzymatic bioreactor (1.5 L) and
an external direct contact membrane distillation system (Figure 1). The glass enzymatic bioreactor
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covered with aluminum foil was placed in a water bath, and the temperature of the water bath was
maintained at 30 ± 0.2 ◦C using an immersion heating unit (Julabo, Seelbach, Germany). The enzymatic
bioreactor was equipped with an air pump (ACO-002, Zhejiang Sensen Industry Co. Ltd., Zhoushan,
China) to maintain a dissolved oxygen concentration of above 3 mg/L.Appl. Sci. 2017, 7, 879 4 of 15 
 
Figure 1. Schematic representation of the membrane distillation—enzymatic membrane bioreactor 
(MD-EMBR). 
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cell, two circulation pumps (Micropump Inc., Vancouver, WA, USA) and a glass permeate tank 
(Figure 1). Feed and permeate flow channels were engraved on each block of the membrane cell. 
Length, width and height of each flow channel were 145, 95 and 3 mm, respectively. 
A hydrophobic microporous polytetrafloroethylene (PTFE) membrane (GE, Minnetonka, MN, 
USA) was used during each experiment. The PTFE membrane has a nominal pore size of 0.22 µm, 
thickness of 175 µm, porosity of 70% and an active layer thickness of 5 µm [35]. 
2.3. Experimental Protocol 
A series of experiments was carried out to evaluate the performance of MD-EMBR for TrOC 
degradation. At the start of the experiment, a mixture of the selected TrOCs (each at 20 µg/L) in Milli-
Q water was added to the bioreactor. Laccase was added to the bioreactor for achieving an initial 
enzymatic activity of 95–100 µM(DMP)/min. The media from the glass enzymatic bioreactor and water 
from the permeate tank were recirculated in their respective flow channels separated by the 
membrane. A chiller (SC100-A10, Thermo Scientific, Waltham, MA, USA) was used to regulate the 
temperature of the permeate tank at 10 ± 0.1 °C. The permeate tank was also placed on a precision 
balance (Mettler Toledo Inc., Columbus, OH, USA) to monitor permeate flux. The recirculation flow 
rate of both feed and the distillate was controlled at 1 L/min (corresponding to the cross flow velocity 
of 9 cm/s) using two rotameters. 
Duplicate samples from the enzymatic bioreactor (100 mL each) and permeate tank (500 mL 
each) were taken after operating the MD-EMBR for 12 h. After evaluating the laccase-catalyzed 
Figure 1. Schematic representation of the membrane distillation—enzymatic embrane bioreactor
(MD-EMBR).
The external direct contact membrane distillation system contained an acrylic glass membrane
cell, two circulation pumps (Micropump Inc., Vancouver, WA, USA) and a glass permeate tank
(Figure 1). Feed and permeate flow channels were engraved on each block of the membrane cell.
Length, width and height of each flow channel were 145, 95 and 3 mm, respectively.
A hydrophobic microporous polyte rafloroethylene (PTFE) membrane (GE, Minnetonka, MN,
USA) was used during each experiment. The PTFE membrane has a nominal pore size of 0.22 µm,
thickness of 175 µm, porosity of 70% and an active layer thickness of 5 µm [35].
2.3. Experimental Protocol
A series of experiments was carried out to evaluate the performance of MD-EMBR for TrOC
degradation. At the start of the experiment, a mixture of the selected TrOCs (each at 20 µg/L) in
Milli-Q water was added to the bioreactor. Laccase was added to the bioreactor for achieving an initial
enzymatic activity of 95–100 µM(DMP)/min. The media from the glass enzymatic bioreactor and water
from the permeate tank were recirculated in their respective flow channels separated by the membrane.
A chiller (SC100-A10, Thermo Scientific, Waltham, MA, USA) was used to regulat the temperature of
the permeate ank at 10 ± 0.1 ◦C. The permeat tank was als placed o a precision balance (Mettler
Toledo Inc., Columbus, OH, USA) to monitor permeate flux. The recirculation flow rate of both feed
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and the distillate was controlled at 1 L/min (corresponding to the cross flow velocity of 9 cm/s) using
two rotameters.
Duplicate samples from the enzymatic bioreactor (100 mL each) and permeate tank (500 mL each)
were taken after operating the MD-EMBR for 12 h. After evaluating the laccase-catalyzed degradation
of TrOCs in MD-EMBR, the possible improvement in TrOC degradation was assessed with the addition
of three redox-mediators (HBT, VA and SA) at two different concentrations (0.25 and 0.5 mM) via
separate runs. Again duplicate samples from the enzymatic bioreactor and permeate tank were
collected for the quantification of TrOCs.
Samples collected from the enzymatic bioreactor were diluted to 500 mL with Milli-Q water and
were filtered through 0.45 µm glass fiber filter paper (Filtech, Wollongong, NSW, Australia). The pH
of samples was adjusted to 2–2.5 using 4 M H2SO4 before solid phase extraction (SPE) and GC/MS
analysis. For toxicity analysis, undiluted samples from the enzymatic bioreactor and permeate tank
were collected in 2 mL amber vials at the end of each experiment, and stored at 4 ◦C until analysis.
2.4. Analytical Methods
2.4.1. TrOC Analysis
The concentration of TrOCs was measured using an analytical method involving SPE
derivatization and quantitative determination by a Shimadzu GC/MS (QP5000) system as described
by Hai et al. [36]. Limit of detection (LOD) for this method was compound specific and ranged from
1 to 20 ng/L (see Supplementary Data Table S1). Removal efficiencies by the enzymatic bioreactor (R1)
and the MD-EMBR (R2) were calculated using Equations (1) and (2), respectively:
R1 = 100 × (1 − Cf/Co) (1)
R2 = 100 × (1 − Cp/Co) (2)
where, Co and Cf are the concentration (ng/L) of specific TrOC in the enzymatic bioreactor at the
beginning (t = 0 h) and end (t = 12 h) of experiment, respectively, while Cp is the concentration of
specific TrOC in permeate at t = 12 h. The enzymatic transformation/degradation of TrOCs in the
MD-EMBR was calculated using Equation (3):
Co × Vo = (Cf × Vf) + (Cp × Vp) + biodegradation (3)
where, Vo, Vf and Vp represents the volume of feed (at t = 0 h), supernatant (t = 12 h) and permeate
(t = 12 h), respectively.
2.4.2. Enzymatic Activity, ORP and Toxicity Assay
Laccase activity and effluent toxicity were examined as described elsewhere [18]. Laccase activity
was measured by recording the change in absorbance at 468 nm due to the oxidation of 2,6-dimethoxyl
phenol (DMP) in the presence of 100 mM sodium citrate (pH 4.5). Laccase activity expressed as
µM(DMP)/min was then calculated from the molar extinction coefficient of 49.6/mM cm. Oxidation
reduction potential (ORP) was measured at the start and end of each experiment using an ORP meter
(WP-80D dual pH-mV meter, Thermo Fisher Scientific, Scoresby, VIC, Australia). Samples for toxicity
analysis were collected from the enzymatic bioreactor and permeate tank at end of each experiment.
Toxicity, expressed as a relative toxicity unit (rTU), was analyzed by measuring the inhibition
of luminescence in the naturally bioluminescent bacteria, Photobacterium leiognathi, as previously
described [37,38].
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3. Results and Discussion
3.1. Overall Removal of TrOCs
In theory, MD membranes can retain all but the volatile organic compounds. In this study,
the concentration of non-volatile (pKH > 9) TrOCs in the permeate of the MD-EMBR was below the
limit of detection of GC/MS. This is consistent with the observation in a previous study, where an MD
membrane was coupled with an activated sludge bioreactor [22]. On the other hand, the MD system
achieved 90–99% removal of relatively volatile TrOCs having pKH < 9 (Figure 2). This compares
favorably to their previously reported moderate to high removal (54–99%) by a standalone MD
system [29]. In particular, removal of octocrylene (pKH = 8.47), benzophenone (pKH = 5.88),
4-tert-butylphenol (pKH = 5.15), 4-tert-octylphenol (pKH = 5.06) by the MD-EMBR was above 99%,
compared to their 55–70% removal by the MD only [29]. These results suggest that the coupling of
enzymatic degradation process to the MD system was favorable for achieving high TrOC removal.
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Figure 2. Overall removal and enzymatic degradation of 30 TrOCs in the MD-EMBR. Error bars 
indicate the standard deviation of duplicate samples. MD-EMBR operating conditions: the initial 
TrOC concentration and laccase activity was 20 µg/L and 95–100 µM(DMP)/min, respectively; 
temperature of the enzymatic bioreactor and the permeate tank were kept at 30 and 10 °C, 
respectively; and cross-flow rate of media from the enzymatic bioreactor and distillate was 1 L/min 
(corresponding to a cross-flow velocity of 9 cm/s). 
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laccase with concomitant reduction of atmospheric oxygen to water. The extent of degradation 
depends on, among others, the molecular properties (e.g., EWGs, EDGs or phenolic moiety) of the 
target substrate [11,39]. In this study, high degradation (87–99%) of 10 out 13 phenolic TrOCs was 
achieved by the MD-EMBR (Figure 2). These included five steroid hormones (estriol, estrone, 17β–
estradiol, 17α–ethinylestradiol and 17β-estradiol-17-acetate (95–99%)), two industrial chemicals (4-
tert-butylphenol, and 4-tert-octylphenol (87–99%)) and two personal care products (oxybenzone and 
triclosan (89–98%)). On the other hand, enzymatic degradation of some phenolic compounds, namely 
pentachlorophenol, enterolactone and salicylic acid, ranged from 55 to 75%. Their incomplete 
degradation, despite the presence of a strong EDG (i.e., hydroxyl group), can be attributed to the 
concomitant presence of an EWG (e.g., halogen) in their molecular structure (see Supplementary Data 
Table S1) [39]. 
Depending on the medium ORP, laccase can also degrade non-phenolic compounds. However, 
the reaction kinetics can be slow [17,39]. In this study, the enzymatic degradation of 17 non-phenolic 
Figure 2. Overall removal and enzymatic degradation of 30 TrOCs in the MD-EMBR. Error bars
indicate the standard deviation of duplicate samples. MD-EMBR operating conditions: the initial TrOC
concentration and laccase activity was 20 µg/L and 95–100 µM(DMP)/min, respectively; temperature of
the enzy atic bioreactor and the permeate tank were kept at 30 and 10 ◦C, respectively; and cross-flow
rate of media from the enzymatic bi reactor and distillate was 1 L/min (corresponding to a cross-flow
velocity of 9 cm/s).
3.2. TrOC Degradation in Enzymatic Bioreactor
Degradation of a substrate by laccase involves the transfer of an electron from the substrate
to laccase with concomitant reducti n of atmospheric oxygen to water. The extent of degradation
depends on, among others, the molecular properties (e.g., EWGs, EDGs or phenolic moiety) of
the target substrate [11,39]. In this study, high degradation (87–99%) of 10 out 13 phenolic TrOCs
was achieved by the MD-EMBR (Figure 2). These included five steroid hormones (estriol, estrone,
17β–estradiol, 17α–ethinylestradiol and 17β-estradiol-17-acetate (95–99%)), two industrial chemicals
(4-tert-butylphenol, and 4- rt-octylphenol (87–99%)) and two personal care products (oxybenzone
Appl. Sci. 2017, 7, 879 7 of 15
and triclosan (89–98%)). On the other hand, enzymatic degradation of some phenolic compounds,
namely pentachlorophenol, enterolactone and salicylic acid, ranged from 55 to 75%. Their incomplete
degradation, despite the presence of a strong EDG (i.e., hydroxyl group), can be attributed to the
concomitant presence of an EWG (e.g., halogen) in their molecular structure (see Supplementary Data
Table S1) [39].
Depending on the medium ORP, laccase can also degrade non-phenolic compounds. However,
the reaction kinetics can be slow [17,39]. In this study, the enzymatic degradation of 17 non-phenolic
TrOCs varied from 40–99% (Figure 2). Laccase catalyzed degradation of 13 compounds fell in the
range of 40–65%, while the degradation of the remaining four TrOCs was in the range of 94–98%.
The well degraded non-phenolic TrOCs include metronidazole, benzophenone, amitriptyline and
octocrylene. High laccase-catalyzed degradation (80–99%) in continuous flow UF-EMBR has been
previously reported [18,37] for benzophenone, amitriptyline and octocrylene, but not for metronidazole.
Metronidazole contains both EWGs (i.e., –NO2) and EDGs (i.e., methyl and hydroxyethyl) in its
molecule (see Supplementary Data Table S1). High enzymatic degradation of metronidazole following
its complete retention by the MD membrane in MD-EMBR can be attributed to the prolonged contact
time that may have promoted the interaction of laccase with the EDGs of metronidazole.
An overall degradation of only 40–65% was achieved by the MD-EMBR for a number of
non-phenolic TrOCs (Figure 2), however, these removal efficiencies in fact compare favorably with
those reported in the literature [12,15,37]. For instance, laccase catalyzed degradation of carbamazepine,
clofibric acid, fenoprop and atrazine has been reported to be less than 10% in both batch and continuous
flow ultrafiltration based enzymatic bioreactors [15,18,40]. By contrast, 40–45% degradation of these
TrOCs by the MD-EMBR was observed in this study. Since most of the selected non-phenolic TrOCs
contain both EWGs and EDGs in their structure (see Supplementary Data Table S1), complete retention
of these TrOCs in the enzymatic bioreactor may have facilitated the interaction of EDGs with nearby
redox centers, thereby providing higher possibility of electron transfer to enzyme [17]. Previously,
Nguyen et al. [20] reported that dosing of GAC into an UF-EMBR led to simultaneous adsorption of
laccase and TrOCs on GAC, yielding significant improvement in the degradation of four non-phenolic
TrOCs, namely atrazine, sulfamethoxazole, diclofenac and carbamazepine. Although our approach
was different, it is conceivable that prolonged retention of TrOCs in the enzymatic bioreactor can
improve their degradation.
It is noteworthy that phenolic TrOCs (e.g., triclosan, oxybenzone, bisphenol A and steroid
hormones) can act as redox-mediators, and the fragments of phenoxyl radicals formed following
their degradation by laccase can oxidize non-phenolic compounds [39]. Indeed Margot et al. [12]
observed that degradation of diclofenac by laccase was significantly higher in the mixture of TrOCs
containing diclofenac, bisphenol A and mefenamic acid than its degradation as a single compound.
It is possible that complete retention of phenoxyl radicals formed due to the degradation of phenolic
TrOCs aided better degradation of non-phenolic TrOCs by MD-EMBR as compared to previously
developed UF-EMBR [18,37]. Further investigation would be required to substantiate this hypothesis
but that is beyond the scope of this study.
This study confirms for the first time the improvement in TrOC degradation in an enzymatic
bioreactor by coupling with it a high retention membrane (such as membrane distillation) as compared
to a conventional ultrafiltration membrane. We used a direct contact membrane distillation module,
but there may be case-specific scope of choice between different formats of membrane distillation.
Future studies are recommended to assess the commercial viability of different configurations of MD
such as vacuum MD and air gap MD, but that is beyond the scope of this study.
3.3. Impact of Mediator Addition on TrOC Degradation
As noted in Section 3.2, of the 30 TrOCs tested, MD-EMBR achieved high degradation (85–99%)
for 14 compounds (10 phenolic and 4 non-phenolic compounds) but the degradation efficiency varied
widely (40–70%) for the rest of the compounds. To improve the degradation of the latter group,
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three redox-mediators, namely SA, VA and HBT, were added at 0.25 and 0.5 mM concentrations each
in separate runs. Depending on the redox-mediator type and concentration, degradation of phenolic
compounds and non-phenolic compounds by the MD-EMBR was improved by 20–30% and 10–50%,
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Figure 3. Enzymatic degradation of 30 TrOCs in the presence of three mediators, namely HBT, VA 
and SA (separately at 0.5 mM) in the MD-EMBR. Error bars indicate the standard deviation of 
duplicate samples. Operating conditions of the MD-EMBR are given in the caption of Figure 2. 
3.3.1. Comparison of Redox-Mediators 
To date, the impact of redox-mediator type on the improvement of TrOC degradation has been 
assessed mainly in small scale and batch tests [34,41,42]. For instance, Ashe et al. [34] investigated the 
performance of seven different redox-mediators including SA, HBT and VA for the degradation of 
four resistant TrOCs, namely atrazine, naproxen, oxybenzone and pentachlorophenol in 10 mL batch 
reactors. They achieved significant improvement (40–90%) at a concentration of 1 mM. Nguyen et al. 
[18] achieved enhanced (10–90%) removal of TrOCs in UF-EMBR using SA and HBT. However, this 
is the first study investigating the efficacy of SA, VA and HBT for enhanced degradation of a broad 
spectrum of TrOCs by an MD-EMBR. 
All the tested redox-mediators enhanced the degradation of TrOCs. However, the best overall 
performance was shown by VA (Figure 3). In line with the findings of Nguyen et al. [37], degradation 
of the phenolic TrOCs that were already highly degraded by laccase (Figure 2) remained almost the 
same after the addition of redox-mediators. For the remaining phenolic TrOCs, VA (at 0.5 mM), 
compared to HBT and SA achieved better removal for two compounds, namely salicylic acid (80%) 
and pentachlorophenol (90%). Both VA and SA achieved above 95% degradation of enterolactone, 
which compares favorably with 45–70% degradation achieved in absence of mediators (Figure 3). 
Of the 17 non-phenolic compounds, degradation of four compounds viz metronidazole, 
benzophenone, amitriptyline and octocrylene, was at least 90%, regardless of the mediator type 
(Figure 3). For the remaining compounds, VA (at 0.5 mM) achieved better degradation for 10 
compounds compared to SA and HBT. SA (at 0.5 mM) performed the best for the degradation of two 
compounds, namely naproxen and primidone. It is well-known that the herbicide atrazine is resistant 
to laccase catalyzed degradation [18]. Compared to other redox-mediators, HBT was particularly 
efficient (>99%) for the degradation of atrazine. Although a superior ability of VA compared to other 
mediators for the degradation of non-phenolic TrOCs has been reported previously in a batch 
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3.3.1. Comparison of Redox-Mediators
To date, the impact of redox-mediator type on the improvement of TrOC degradation has been
assessed mainly in small scale and batch tests [34,41,42]. For instance, Ashe et al. [34] investigated
the performance of seven ifferent redox-m diators including SA, HBT and VA for th degradation
of four resistant TrOCs, namely atrazine, naproxen, oxybenzone and pentachlor phenol in 10 mL
batch reactors. They achieved significant improvement (40–90%) at a concentration of 1 mM.
Nguyen et al. [18] achieved enhanced (10–90%) removal of TrOCs in UF-EMBR using SA and HBT.
However, this is the first study investigating the efficacy of SA, VA and HBT for enhanced degradation
of a broad spectrum of TrOCs by an MD-EMBR.
All the tested redox-mediators enhanced the deg ad tion of TrOCs. However, the best overall
performance was shown by VA (Figure 3). In line with the findings of Nguyen et al. [37], degradation of the
phenolic TrOCs that were already highly degraded by laccase (Figure 2) remained almost the same after
the addition of redox-mediators. For the remaining phenolic TrOCs, VA (at 0.5 mM), compared to HBT
and SA achieved better removal for two compounds, namely salicylic acid (80%) and pentachlorophenol
(90%). Both VA and SA achieved above 95% degradation of enterolactone, which compares favorably with
45–70% degradation achieved in absence of mediators (Figure 3).
Of the 17 non-phenolic compounds, degradation of four compounds viz metronidazole,
benzophenone, amitriptyline and octocrylene, was at least 90%, regardless of the mediator type
(Figure 3). For the remaining compounds, VA (at 0.5 mM) achieved better degradation for
10 compounds compared to SA and HBT. SA (at 0.5 mM) performed the best for the degradation of two
compounds, namely naproxen and primidone. It is well-known that the herbicide atrazine is resistant
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to laccase catalyzed degradation [18]. Compared to other redox-mediators, HBT was particularly
efficient (>99%) for the degradation of atrazine. Although a superior ability of VA compared to
other mediators for the degradation of non-phenolic TrOCs has been reported previously in a batch
enzymatic bioreactor spiked with four TrOCs [34], the effectiveness of VA for the degradation of
a broad spectrum of non-phenolic TrOCs is demonstrated for the first time in this study.
3.3.2. Impact of Mediator Concentration
Redox-mediator dose can affect TrOC degradation by changing the abundance, stability and
reversibility of the generated radicals [43]. Therefore, the impact of two mediator concentrations
(0.25 and 0.5 mM) on ORP, TrOC degradation, and enzyme stability was investigated.
Concentration-dependent improvement in the degradation of 18 TrOCs (5 phenolic and
13 non-phenolic compounds, Figure 4) was observed in MD-EMBR. The highest improvement in
the degradation of TrOCs was achieved at 0.5 mM. Notably, increasing the concentration of SA,
HBT and VA from 0.25 to 0.5 mM improved TOC degradation by up to 7%, 15% and 25%, respectively
(Figure 4). This corresponds well with the respective increase of 2%, 5% and 15% of the reaction
media ORP (Figure 5). On the other hand, degradation of 8 phenolic and 4 non-phenolic TrOCs in
MD-EMBR was comparable at all the tested mediator concentrations (Supplementary data Figure S3).
For instance, HBT achieved over 99% degradation of atrazine in MD-EMBR irrespective of the mediator
concentration. This is consistent with HBT performance reported in case of UF-EMBR [18].
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Figure 4. Impact of mediator concentration (0.25 and 0.5 mM) on the degradation of TrOCs in the MD-
EMBR. Error bars indicate the standard deviation of duplicate samples. Operating conditions of the 
MD-EMBR are given in the caption of Figure 2. Only those TrOCs showing mediator concentration-
dependent improvement in their degradation are shown here. For remaining TrOCs, results are given 
in Supplementary Data Figure S3. 
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Figure 5. Effect of mediator type and concentration on oxidation reduction potential (ORP) and 
laccase inactivation in the MD-EMBR. Operating conditions of the MD-EMBR are given in the caption 
of Figure 2. 
In general, the degradation of TrOCs that are easily amenable to laccase (Supplementary data 
Figure S3) does not improve significantly (less than 5% in this study), while the degradation of resistant 
TrOCs (Figure 4) may improve with the increase in mediator concentration, and may reach a plateau 
beyond a certain mediator concentration. However, the mediator concentration beyond which no 
improvement occurs may depend on the type of mediators as well as the target TrOCs [41,44]. 
3.3.3. Effect of Mediators on Enzyme Stability 
In this study, a gradual inactivation of laccase was observed despite the absence of any known 
chemical inhibitors in the synthetic wastewater (Figure 5). In the absence of redox-mediators, a 37% 
laccase inactivation was observed over a period of 12 h. This was possibly due to the blockage of the 
active enzyme sites by the charged metabolites and/or hydraulic stress during membrane filtration 
[25,41]. Since the MD membrane can conceptually retain all nonvolatile organics including the 
transformation products/radicals, laccase inactivation with or without the presence of redox-
mediators can be expected. The extent of laccase inactivation increased further when the mediators 
were added (61%, 66% and 73% for HBT, SA and VA, respectively, each at a concentration of 0.5 mM). 
The highly reactive radicals generated from mediators can enhance the degradation of TrOCs but at 
the same time may inactivate laccase [45]. Purich [17] suggested that the metabolites from the 
oxidation of substrate and/or mediators could react with enzyme to form non-productive complexes, 
thereby inactivating the enzyme. 
The extent of laccase inactivation also depends on the concentration of redox-mediators. For 
instance, Khlifi-Slama et al. [45] observed a gradual increase in the inactivation of laccase from 
Trametes trogii following a stepwise increase in the concentration of HBT from 0.1 to 10 mM. In 
another study, increasing SA concentration from 0.1 to 1 mM resulted in aggravated inactivation of 
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In general, the degradation of TrOCs that are easily amenable to laccase (Supplementary data
Figure S3) does not improve significantly (less than 5% in this study), while the degradation of resistant
TrOCs (Figure 4) may improve with the increase in mediator concentration, and may reach a plateau
beyond a certain mediator concentration. However, the mediator concentration beyond which no
improvement occurs may depend on the type of mediators as well as the target TrOCs [41,44].
3.3.3. Effect of Mediators on Enzyme Stability
In this study, a gradual inactivation of laccase was observed despite the absence of any known
chemical inhibitors in the synthetic wastewater (Figure 5). In the absence of redox-mediators,
a 37% laccase inactivation was observed over a period of 12 h. This was possibly due to the blockage
of the active enzyme sites by the charged metabolites and/or hydraulic stress during membrane
filtration [25,41]. Since the MD membrane can conceptually retain all nonvolatile organics including the
transformation products/radicals, laccase inactivation with or without the presence of redox-mediators
can be expected. The extent of laccase inactivation increased further when the mediators were added
(61%, 66% and 73% for HBT, SA and VA, respectively, each at a concentration of 0.5 mM). The highly
reactive radicals generated from mediators can enhance the degradation of TrOCs but at the same time
may inactivate laccase [45]. Purich [17] suggested that the metabolites from the oxidation of substrate
and/or mediators could react with enzyme to form non-productive complexes, thereby inactivating
the enzyme.
The extent of laccase inactivation also depends on the concentration of redox-mediators. For instance,
Khlifi-Slama et al. [45] observed a gradual increase in the inactivation of laccase from Trametes trogii
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following a stepwise increase in the concentration of HBT from 0.1 to 10 mM. In another study, increasing
SA concentration from 0.1 to 1 mM resulted in aggravated inactivation of laccase from Trametes versicolor [42].
These results suggest that the degree of laccase inactivation is strongly influenced by redox-mediator
concentration. Indeed, loss in laccase activity was increased by 7%, 9% and 11% in MD-EMBR due
to the increase in the concentration of HBT, SA and VA, respectively, from 0.25 to 0.5 mM (Figure 5).
Although laccase activity was greatly affected in the presence of redox-mediators, it was compensated by
the improvement in TrOC degradation (Figure 3). For example, the highest drop in laccase activity was
observed in the presence of VA (Figure 5), but it outperformed SA and HBT in terms of enhanced TrOC
degradation (Figure 3).
3.4. Effluent Toxicity
The charged metabolites and highly reactive radicals produced following the oxidation of
redox-mediators may improve TrOC degradation [18,46], but these can also cause an increase
in effluent toxicity [18,47]. In this study, it was not possible to relate individual metabolites to
specific parent compounds because we investigated a mixture of 30 TrOCs. Hence, the overall
bacterial toxicity of the reaction mixture and permeate was evaluated at the end of each run.
Of the three mediators tested, SA significantly increased the toxicity of the solution in the enzymatic
bioreactor, whereas HBT and VA showed no effect on toxicity levels (Table 2). Compared to the
background toxicity of the mixture of laccase and TrOCs in the enzymatic bioreactor of MD-EMBR
(<1 to 1.8 rTU; n = 2), toxicity in the enzymatic bioreactor due to addition of HBT, VA and SA
ranged from <1 to 1.7 rTU (n = 2), 3.3 to 3.9 rTU (n = 2) and 109 to 116 rTU (n = 2), respectively.
Notably, the final effluent (i.e., membrane permeate) was not toxic to bacteria (<1 rTU) for any of
the enzyme/mediator combinations, indicating that MD not only retained TrOCs and laccase but also
the transformation byproducts and radicals responsible for inducing bacterial toxicity. This is an added
advantage of coupling a high retention membrane to the enzymatic bioreactor.
Table 2. Toxicity of the reactor mixture and permeate following treatment of TrOCs with different
mediators in MD-EMBR, expressed as relative toxic unit (rTU). Mediators were added separately
at a concentration of 0.5 mM. The limit of detection of the toxicity assay was 10% inhibition of
luminescence (i.e., 1 rTU). Toxicity in all permeate samples was below the limit of detection (n = 2).
Reaction Mixture Toxicity of the Reactor Mixture (rTU) Toxicity of the Permeate (rTU)
TrOCs + Laccase <1–1.8 <1
TrOCs + Laccase + HBT (0.5 mM) <1–1.7 <1
TrOCs + Laccase + VA (0.5 mM) 3.3–3.9 <1
TrOCs + Laccase + SA (0.5 mM) 109–116 <1
3.5. Permeate Flux
The driving force of permeate flux in MD is the difference between feed and distillate temperature.
Ideally, feed and distillate temperature is maintained at over 50 and 20–25 ◦C, respectively to obtain
a permeate flux of approximately 10 L/m2 h [27,48]. In this study, however, to avoid thermal
inhibition of laccase [46], temperature of the enzymatic reactor and permeate tank was kept at
30 and 10 ◦C, respectively. A stable permeate flux of around 4 L/m2 h was observed during all
experiments (Supplementary Data Figure S4), suggesting that membrane fouling did not occur
during the operation period. This level of flux is consistent with the feed temperature employed.
Notably, the average permeate flux (Figure 6) for laccase only, laccase-HBT, laccase-VA and laccase-SA
variations was 3.69 ± 0.44 L/m2 h (n = 150), 3.89 ± 0.63 L/m2 h (n = 283), 3.92 ± 0.62 L/m2 h (n = 291)
and 3.86 ± 0.66 L/m2 h (n = 288) LMH, respectively, confirming negligible impact of different type
of mediator addition on membrane flux. In this study, the mass transfer coefficient (Km) of the
DCMD, which was calculated based on the method described by Nghiem et al. [49], ranged from
1.22 to 1.28 (×10−3) L/m2 h Pa. This value is in good agreement with that in previous studies [48,50].
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Thus, this study shows both stable membrane hydraulic performance and improved enzymatic























































































Figure 6. Permeate flux during the operation of MD-EMBR with and without the presence of redox-
mediators. Box-and-whisker plot shows the interquartile range; median (horizontal line in the box); 
min and max (whiskers); average (small square in the box); and 1 and 99% percentiles (cross above 
and below the whiskers). Operating conditions for MD-EMBR: Temperature of the enzymatic 
bioreactor and the permeate tank were kept at 30 and 10 °C, respectively; cross-flow rate of water 
from enzymatic bioreactor and distillate was 1 L/min (corresponding to cross-flow velocity of 9 cm/s); 
the initial TrOC concentration and laccase activity was 20 µg/L and 95–100 µM(DMP)/min, respectively; 
and each mediator was added at 0.25 or 0.5 mM concentration in separate runs. 
4. Conclusions 
Performance of an enzymatic bioreactor integrated with the MD system (MD-EMBR) was 
examined for the removal of 13 phenolic and 17 non-phenolic compounds. Based on permeate 
quality, MD-EMBR achieved 90–99% TrOC retention. Degradation of TrOCs varied (40–99%) 
depending on their molecular properties (electron withdrawing functional groups electron donating 
functional groups and phenolic moiety). High degradation (above 90%) of TrOCs containing EDGs 
in their chemical structure was observed in the MD-EMBR, while those containing EWGs in their 
molecular structure were moderately degraded (40–75%). Degradation of TrOCs was further 
improved by adding three redox-mediators, namely syringaldehyde (SA), violuric acid (VA) and 1-
hydroxybenzotriazole (HBT). VA at 0.5 mM concentration was found to be the most effective 
mediator for improving the degradation of phenolic and non-phenolic TrOCs. Moreover, it was 
observed that the degradation of non-phenolic compounds in laccase-mediator system was strongly 
influenced by the tested concentration of the redox-mediators. Despite an increase in the toxicity of 
the reaction mixture caused by SA, the final effluent of the MD-EMBR was nontoxic. 
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3417/7/9/879/s1, 
Table S1: Physicochemical properties of the selected trace organic contaminants (TrOCs), Table S2: 
Physicochemical properties of the selected redox-mediators, Figure S3: Impact of mediator concentration (0.25 
i r . Permeate flux during the operati n of MD-EMBR with and wit out th presence of
redox-mediators. Box-and-whisker plot shows the interquartile range; median (horizontal line in
the box); in and max (whiskers); average (small square in the box); and 1 and 99% percentiles (cross
above and below the whiskers). Operating conditions for MD-EMBR: Temperature of the enzy atic
bioreactor and the per eate tank ere kept at 30 and 10 ◦ , respectively; cross-flo rate of ater
fro enzy atic bioreactor and distillate was 1 L/ in (corresponding to cross-flo velocity of 9 c /s);
the initial TrOC concentration and laccase activity was 20 µg/L and 95–100 µM(DMP)/ in, respectively;
and each ediator was added at 0.25 or 0.5 concentration in separate runs.
(
i for the removal of 13 phenolic and 17 non-phenolic c mpounds. Based on permeate quality,
MD-EMBR achieved 90–99% TrOC retention. Degradation of TrOCs varied (40–99%) depending
on their molecular prop rties (electron withdrawing functional groups elect n donating functional
groups and phenolic moi ty). High degradation ( bove 90%) of TrOCs containing EDGs in their
chemical structure was observed in the MD-EMBR, while those containing EWGs in their molecula
structure were moderately degraded (40–75%). D gradation of TrOCs w s further improved by adding
three redox-me iators, namely syringaldehyde (SA), violuric acid (VA) and 1-hydroxybenzotriazole
(HBT). VA at 0.5 mM concentration was found t be the m st effective mediator for i proving th
degradation of phenolic and non-phen lic TrOCs. Moreover, it was observed that the deg adation
f non-phenolic compounds in laccase-mediat r system was strongly nfluenced by the tested
Appl. Sci. 2017, 7, 879 13 of 15
concentration of the redox-mediators. Despite an increase in the toxicity of the reaction mixture
caused by SA, the final effluent of the MD-EMBR was nontoxic.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3417/7/9/879/s1,
Table S1: Physicochemical properties of the selected trace organic contaminants (TrOCs), Table S2: Physicochemical
properties of the selected redox-mediators, Figure S3: Impact of mediator concentration (0.25 and 0.5 mM) on the
degradation of after an incubation time of 12 h in the MD-EMBR. Error bars indicate the standard deviation of
duplicate samples. Degradation of these TrOCs did not improve by increasing mediator concentration, Figure S4:
Permeate flux obtained during the operation of enzymatic membrane distillation (MD-EMBR) with and without
the addition of redox mediators.
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